Search Results - "Johansen Taber, K."

Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey by Stanek, E J, Sanders, C L, Taber, K A Johansen, Khalid, M, Patel, A, Verbrugge, R R, Agatep, B C, Aubert, R E, Epstein, R S, Frueh, F W

“…To develop a benchmark measure of US physicians' level of knowledge and extent of use of pharmacogenomic testing, we conducted an anonymous, cross‐sectional,…”
Get full text

Next-generation counseling: a model for carrier screening results disclosure and patient management by Arjunan, A., Ben-Shachar, R., Kostialik, J., Johansen Taber, K.

Get full text

Clinical utility of preconception expanded carrier screening by Johansen Taber, K., Lazarin, G., Beauchamp, K., Arjunan, A., Muzzey, D., Wong, K., Goldberg, J.

Get full text

Adoption of PharmacogenomicTesting by US Physicians: Results of a Nationwide Survey by STANEK, E. J, SANDERS, C. L, JOHANSEN TABER, K. A, KHALID, M, PATEL, A, VERBRUGGE, R. R, AGATEP, B. C, AUBERT, R. E, EPSTEIN, R. S, FRUEH, F. W

Get full text

Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties by Johansen Taber, Katherine A, Dickinson, Barry D

“…The use of pharmacogenomic testing in the clinical setting has the potential to improve the safety and effectiveness of drug therapy, yet studies have revealed…”
Get full text

Genomic-based tools for the risk assessment, management, and prevention of type 2 diabetes by Johansen Taber, Katherine A, Dickinson, Barry D

“…Type 2 diabetes (T2D) is a common and serious disorder and is a significant risk factor for the development of cardiovascular disease, neuropathy, nephropathy,…”
Get full text